Enhancing Cooperation Between Academic Biobanks and Biomedical Industry: Better Mutual Understanding and New Collaborative Models Are Needed
- PMID: 32043910
- PMCID: PMC7476386
- DOI: 10.1089/bio.2019.0095
Enhancing Cooperation Between Academic Biobanks and Biomedical Industry: Better Mutual Understanding and New Collaborative Models Are Needed
Conflict of interest statement
D.S.D. is the owner of the biobanking consulting company, medservice. M.H.R. is a member of the Scientific Advisory Boards of Proscia and Trans-Hit. No conflicts of interest exist for the remaining authors.
References
-
- Puchois P, Miranda LB, Van Gool A. Introduction: The cardinal role of biobanks and human biospecimen collections in biomarker validation: Issues impeding impact of biomarker research outcomes. Comprehensive biomarker discovery and validation for clinical application. R Soc Chem 2013;33:73–110
-
- Chadwick D, Roehrl M. High-quality biobanking for personalized precision medicine: BioSpecimen Sciences at the helm. Diagn Histopathol (Oxf) 2013;19:447–456
-
- Hofman P, Brechot C, Zatloukal K, Dagher G, Clement B. Public-private relationships in biobanking: A still underestimated key component of open innovation. Virchows Arch 2014;464:3–9 - PubMed
-
- Mackenzie F. Biobanking trends, challenges, and opportunities. Pathobiology 2014;81:245–251 - PubMed
-
- Simeon-Dubach D, Watson P. Biobanking 3.0: Evidence based and customer focused biobanking. Clin Biochem 2014;47:300–308 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources